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Abstract
Background—Decisions regarding whether to administer intensive care to extremely premature
infants are often based on gestational age alone. However, other factors also affect the prognosis for
these patients.
Methods—We prospectively studied a cohort of 4446 infants born at 22 to 25 weeks' gestation
(determined on the basis of the best obstetrical estimate) in the Neonatal Research Network of the
National Institute of Child Health and Human Development to relate risk factors assessable at or
before birth to the likelihood of survival, survival without profound neurodevelopmental impairment,
and survival without neurodevelopmental impairment at a corrected age of 18 to 22 months.
Results—Among study infants, 3702 (83%) received intensive care in the form of mechanical
ventilation. Among the 4192 study infants (94%) for whom outcomes were determined at 18 to 22
months, 49% died, 61% died or had profound impairment, and 73% died or had impairment. In
multivariable analyses of infants who received intensive care, exposure to antenatal corticosteroids,
female sex, singleton birth, and higher birth weight (per each 100-g increment) were each associated
with reductions in the risk of death and the risk of death or profound or any neurodevelopmental
impairment; these reductions were similar to those associated with a 1-week increase in gestational
age. At the same estimated likelihood of a favorable outcome, girls were less likely than boys to
receive intensive care. The outcomes for infants who underwent ventilation were better predicted
with the use of the above factors than with use of gestational age alone.
Conclusions—The likelihood of a favorable outcome with intensive care can be better estimated
by consideration of four factors in addition to gestational age: sex, exposure or nonexposure to
antenatal corticosteroids, whether single or multiple birth, and birth weight. (ClinicalTrials.gov
numbers, NCT00063063 and NCT00009633.)
Decisions to initiate or forgo intensive care for extremely premature infants are highly
controversial.1-7 In some centers, intensive care is provided to all very premature infants. In
most centers, intensive care is provided selectively on the basis of specific gestational-age
thresholds. Such care is likely to be routinely administered at 25 weeks' gestation but may be
provided only with parental agreement at 23 to 24 weeks, and only “comfort care” may be
given at 22 weeks. The evidence base providing support for these decisions is limited,5,6 and
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the measurement error in assessing pregnancy length8-13 may exceed the 1-to-2-week
difference in gestational age that often prompts different treatment decisions.2,3,5,7,14-16
To facilitate more informed and better justified decisions, we assessed a large cohort of infants
born at 22 to 25 weeks' gestation in the Neonatal Research Network of the National Institute
of Child Health and Human Development to relate gestational age and other risk factors
assessable at or before birth to the likelihood of death or adverse neurodevelopmental
outcomes.
Methods
Eligibility Criteria
We assessed infants born in 19 centers of the Neonatal Research Network at 22 to 25 completed
weeks17 of gestation (25 completed weeks are equivalent to 25 weeks 0 days to 25 weeks 6
days of postmenstrual age) between January 1, 1998, and December 31, 2003. We excluded
infants with a major anomaly, a birth weight greater than 1000 g or the 97th percentile for
gestational age (suggesting that the gestational age was underestimated9,12), or a birth weight
of less than 401 g (below which few infants receive intensive care). Because we adopted the
perspective of a physician deciding whether to initiate mechanical ventilation for infants
considered very likely to die otherwise, we excluded the 31 infants who survived without
mechanical ventilation (described below).
Risk Factors
We recorded the type of delivery, whether the birth was single or multiple, the child's sex,
exposure or nonexposure to antenatal corticosteroid treatment within 7 days before delivery,
race or ethnic group assigned by maternal report (black [not Hispanic], white [not Hispanic],
Hispanic, or other), and birth weight. On the basis of previous findings,13 the best obstetrical
estimate based on the last menstrual period, early ultrasonographic examination, or other
important prenatal findings was used to calculate gestational age, except in unusual
circumstances when only an estimate by the pediatrician18 was available. Details about the
mother's menstrual history and ultrasonographic findings were not collected. We considered
intensive care to have been provided if mechanical ventilation was initiated. (Nasal continuous
positive airway pressure was unlikely to be administered or successfully used to avoid
mechanical ventilation at 22 to 25 weeks' gestation.19)
Outcome Assessments
Research nurses using standardized definitions collected data before discharge. Standardized
neurodevelopmental assessments were performed at a corrected age of 18 to 22 months by
certified examiners trained in a 2-day hands-on workshop.20 Neurodevelopmental impairment
was defined as a score of 70 or below on either the Psychomotor Developmental Index or the
Mental Developmental Index of the Bayley Scales of Infant Development, second edition (on
a scale of 50 to 150, with 150 indicating the most advanced development), moderate or severe
cerebral palsy,20 bilateral blindness, or bilateral hearing loss requiring amplification. Profound
impairment was defined as a Bayley score below 50 (untestable) or a level of 5 for gross motor
function according to the modified criteria of Palisano et al.21 (on a scale of 0 to 5, with 5
indicating that adult assistance is required to move).20
Benefits of Intensive Care
We assessed the percentage of infants with the following prespecified primary outcomes:
survival, survival without impairment, and survival without profound impairment. To avoid
underestimating the potential benefits of intensive care, the maximum potential percentage of
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infants with favorable outcomes, had all infants received intensive care, was estimated. This
estimation was calculated with the assumption that the percentage of infants with a potentially
favorable outcome among those who had died without undergoing mechanical ventilation
would be the same as the percentage of infants in the same risk category who had a favorable
outcome and who underwent mechanical ventilation. Because infants who did not undergo
ventilation tended to be smaller, sicker, and less mature than infants in the same risk category
who underwent ventilation (data not shown), this approach provides an optimistic estimate.
This estimate can be considered the upper bound for the maximum potential percentage of
study infants with a favorable outcome. These estimates were not intended to indicate the best
outcomes achievable under ideal or future circumstances.
Burdens of Intensive Care
We divided the total number of hospital days or ventilator days before death or discharge home
by the number of survivors in order to calculate an index of the infant distress, resource use,
and costs22 incurred per survivor. Similar calculations were performed to express the burdens
of intensive care per survivor without profound impairment.
We estimated the number of additional hospital or ventilator days that would have been required
if all study infants had been given intensive care, assuming that the additional survivors would
require no fewer mean days per survivor than infants in the same risk category who were given
intensive care. We regard this estimate as being conservative because the infants who died
without receiving intensive care tended to be quite small and immature and might well have
required more resources per survivor. The additional number of hospital or ventilator days per
additional survivor without profound impairment was estimated in a similar manner.
Statistical Analysis
Each outcome for infants who received intensive care was analyzed with the use of a logistic
mixed model23,24 performed with the GLIMMIX procedure in SAS software, version 9.1.2
(SAS Institute). Gestational age, birth weight, sex, exposure or nonexposure to antenatal
corticosteroids, and single or multiple birth were selected a priori as predictor variables on the
basis of previous studies of extremely premature infants.6,25-27 Race or ethnic group as
described above was unrelated to the three outcomes in bivariable and multivariable analyses
and was not included. The type of delivery was also unrelated to death or to either impairment
or profound impairment. The center entered the model as a random intercept to adjust for center
differences while providing parameter estimates to permit center-free predictions.21,22 Each
completed week of gestation was entered as a categorical variable rather than a continuous
variable because the latter resulted in inaccurate estimates of the outcome at 22 and 23 weeks'
gestation. A comparison of observed parameter estimates with distributions derived from a
bootstrap procedure involving 10,000 resamples provided support for the validity of the final
model coefficients. For models of the three main outcomes, the variable estimates were within
0.4 to 2.3% of the median of the bootstrap estimates.
There were no significant interactions between gestational age and other risk factors. Data on
infants not examined at 18 to 22 months were excluded from the denominator in analyses
including neurodevelopmental impairment but were not excluded in analyses of death alone.
In assessing differences among centers, the expected proportion of infants who underwent
ventilation with an adverse outcome was estimated for each center by applying our regression
models to the population of infants who underwent ventilation in that center. The ratio of the
observed to the expected rate was then calculated for each center.
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To compare prognostic assessments based on multiple factors with those based on gestational
age alone, we categorized all infants who underwent ventilation into 24 risk groups according
to birth weight (≤25th, 26th to 75th, and >75th percentile for gestational age), sex, exposure
or nonexposure to antenatal corticosteroids, and single or multiple birth. For each group, the
percentage of infants with an unfavorable outcome was predicted with the use of gestational
age alone and according to gestational age, birth weight, sex, exposure or nonexposure to
antenatal corticosteroids, and single or multiple birth. The observed and estimated rates were
then compared. No adjustment for multiple comparisons was performed. Two-sided P values
of less than 0.05 were considered to indicate statistical significance. We used our models to
develop a simple Web-based tool to estimate the likelihood of a favorable outcome.
Results
The study population of 4446 patients is described in Table 1. The 31 relatively mature infants
(0.7%) who were excluded because they survived without mechanical ventilation had a mean
gestational age of 24.7 weeks and a birth weight of 765 g; 68% were female; 87% were
singletons; and 97% had received antenatal corticosteroids. At 18 to 22 months, none had died;
5 of the 27 examined (19%) had impairment, and none had profound impairment.
As expected, the study infants who did not receive intensive care differed from those who
received intensive care with respect to birth weight, gestational age, exposure or nonexposure
to antenatal corticosteroids, and type of delivery (Table 1). The groups also differed with regard
to race or ethnic group (P = 0.04); the proportion of infants born at 22 and 23 weeks was highest
in the centers with the largest population of black infants. No significant difference in race or
ethnic group was present after adjustment for gestational age and center (P = 0.74). Among
infants who did not survive, the mean (±SD) age at death was 2.0±4.1 hours in the group of
infants who did not receive intensive care and 22.4±45.2 days in the group of infants who did
receive intensive care.
At 18 to 22 months, 49% of the study infants had died, 61% had died or had profound
impairment, and 73% had died or had impairment. The rates for these outcomes according to
the week of gestation were 95%, 98%, and 99%, respectively, among study infants born at 22
weeks; 74%, 84%, and 91% among study infants born at 23 weeks; 44%, 57%, and 72% among
study infants born at 24 weeks; and 25%, 38%, and 54% among study infants born at 25 weeks.
Predictors of Outcome With Intensive Care
The benefit of a 1-week increase in gestational age varied somewhat at different weeks and for
different outcomes (Table 2). In multivariable analyses, increased birth weight (per each 100-
g increment), female sex, any use of antenatal corticosteroids, and singleton birth were each
associated with reductions in risks of death and of death or profound or any neurodevelopmental
impairment that were similar to the reductions associated with a 1-week increase in gestational
age. (The regression equations relating these risk factors to outcomes are provided in Table A
of the Supplementary Appendix, available with the full text of this article at www.nejm.org.)
Depending on these risk factors, the estimated probability of an adverse outcome with intensive
care varied considerably among infants at the same gestational age (see Fig. A and B of the
Supplementary Appendix). For example, among infants born midway between 24 and 25
completed weeks of gestation, the estimated likelihood of death or profound impairment was
33% for a 750-g, appropriate-for-gestational-age female singleton who received antenatal
corticosteroids but 87% for a 525-g, small-for-gestational-age male twin who did not receive
antenatal corticosteroids.
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Outcomes for infants who underwent ventilation varied among centers (P<0.001). Among
centers that contributed data on 100 or more infants who underwent ventilation, the ratio of
the observed to the expected rate of adverse outcomes ranged from 0.60 to 1.38 for death, 0.75
to 1.23 for death or profound impairment, and 0.85 to 1.17 for death or impairment.
Use of Intensive Care and Infant Risk
As expected, the percentage of study infants who received intensive care increased
progressively with increasing gestational age (from 23% at 22 weeks' gestation to 99% at 25
weeks' gestation) and birth weight (from 49% at 401 to 500 g to ≥97% at 701 to 1000 g).
Intensive care was administered to more infants who received antenatal corticosteroids than to
those who did not (94% vs. 58%). However, the percentage of infants who received intensive
care was not significantly greater for singletons than for multiples (83% and 84%, respectively)
or for female infants than for male infants (84% and 83%, respectively). This was also true at
the lowest gestational ages (for female and male infants: 21% and 25%, respectively, at 22
weeks and 65% and 74%, respectively, at 23 weeks). For each major outcome, the percentage
of infants who received intensive care was lower for female infants than male infants and for
singletons than for multiples, after adjustment for the predicted likelihood of a favorable
outcome with intensive care (P<0.01).
Outcome Prediction
The outcomes of the infant risk groups were predicted more accurately with the use of five
factors (gestational age, birth weight, sex, exposure or nonexposure to antenatal corticosteroids,
and single or multiple gestation) than with the use of gestational age alone, particularly for
some subgroups (P<0.001 for the mean absolute difference between predicted and observed
values and for the area under the receiver-operating-characteristic curve) (Table 3). (See Tables
B and C of the Supplementary Appendix for specific subgroup data.)
Benefits of Intensive Care For Small Immature Infants
Even among the study infants at 24 weeks' gestation or less and with a birth weight of 600 g
or less, outcomes varied considerably among different risk groups. The observed and maximum
potential rates of survival without profound impairment were as low as 2 and 5%, respectively,
for boys who weighed 401 to 500 g at 22 weeks' gestation and as high as 37 and 38%,
respectively, for girls who weighed 501 to 600 g at 24 weeks' gestation (Fig. 1).
Burdens of Intensive Care
Among all study infants, the total resource use per survivor and per survivor without profound
impairment was high, particularly at the lowest gestational ages. The total resource use was
consistently greater for male than for female infants (Table 4).
Benefits and Burdens of Universal Intensive Care For Infants at 22 to 23 Weeks
We estimate that providing universal intensive care to all infants who were born at 22 to 23
weeks' gestation would have resulted in at least 1749 extra hospital days and 0 to 9 additional
survivors per 100 infants treated. We estimate that of 0 to 9 additional survivors per 100 infants
treated, 0 to 5 would have survived without profound impairment and 0 to 3 would have
survived without impairment.
Discussion
Our findings challenge the widespread use of gestational-age thresholds alone in deciding
whether to administer intensive care to extremely premature infants. In multivariable models
of infants who received intensive care, female sex, exposure to antenatal corticosteroid therapy,
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singleton birth, and increased birth weight (per 100-g increment) were each associated with
benefits similar to those of an increase in gestational age of approximately 1 week. In bivariable
analyses as well as analyses adjusted for the center and the factors described above, race or
ethnic group had no significant association with outcomes; these findings are similar to those
in a previous Neonatal Research Network study.25 At the same estimated likelihood of a
favorable outcome, the likelihood of receiving intensive care was lower for girls than for boys
and for singletons than for multiples. The likelihood of death or adverse developmental
outcomes among different risk groups was more accurately estimated with the use of multiple
risk factors than with the use of gestational age alone.
Outcomes are likely to be more closely related to gestational age in populations that virtually
always undergo an early ultrasonographic assessment.9,28 Estimates based on
ultrasonographic examinations have been reported to have an error (±2 SD) of approximately
4 days at 12 to 14 weeks29 and 7 days at 14 to 22 weeks.30 However, even early estimates
based on ultrasonographic examinations are subject to both systematic and random error,10,
31-33 and their accuracy has generally been assessed in relatively healthy populations
evaluated by ultrasonographers who are aware of other indicators of pregnancy length. The
error under field conditions at 20 to 30 weeks' gestation may be as great as 2 weeks.14 For
many extremely premature infants, the measurement error in assessing pregnancy
length8-14,29-31 is more than the 1-to-2-week difference in gestational age that would change
treatment decisions with the use of current gestational-age thresholds. The error in estimating
fetal weight should also be considered in antepartum counseling.
For multiple reasons, the effects of intensive care on extremely premature infants are unlikely
to be determined in randomized trials. Observational studies are more subject to bias,
particularly at the lowest gestational ages, when intensive care is used most selectively. Our
study is also limited by the unavailability of data indicating how the obstetrical estimate of
gestational age was assigned, the inability to determine the outcome for 6% of the study infants,
and the use of center-based samples. A population-based study is needed to verify the absence
of an important effect of race or ethnic group on the outcome for extremely premature infants.
The better outcomes for infants who received antenatal corticosteroids result at least in part
from their use when obstetricians are committed to optimizing outcomes.34 Whether the use
of corticosteroids has a benefit before 26 weeks' gestation remains to be determined in
randomized trials.35
The strengths of our study include a prospective evaluation of a large, heterogeneous cohort
and assessment of profound impairment, an outcome that some persons consider to be worse
than death.36,37 Total ventilator days or hospital days before discharge per infant with a
favorable outcome were computed as indexes of cost, resource use, parental distress, and infant
suffering due to painful procedures, prolonged intubation, and such complications as
intracranial hemorrhage, necrotizing enterocolitis, and recurrent episodes of hypoxia.5
Conventional analyses of cost-effectiveness are problematic for neonatal intensive care,5 and
we did not attempt to measure short-term or long-term financial costs. However, current costs
before discharge may be estimated at approximately $3,400 per hospital day (2007 U.S. dollars,
based on the estimates of Schmitt et al.22 and adjusted for inflation38). Barring major
therapeutic advances, our findings indicate that extending intensive care to all of the most
immature infants would entail considerable suffering, resource use, and cost in order to benefit
only a small proportion of infants.
When are the burdens of intensive care justified by the likelihood of benefit? Traditional
estimates of this likelihood are based on the proportion of births of infants in the highest-risk
groups with a good outcome. Because some infants die without receiving intensive care, this
approach underestimates the likelihood of a benefit from intensive care. To avoid this problem
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and provide an upper bound for the likelihood of such a benefit, we assessed the maximum
potential benefit, assuming the same outcome among infants who died without receiving
intensive care as among infants who received intensive care in the same risk category. In any
risk category, the true likelihood of a benefit from intensive care is likely to be intermediate
between the observed and maximum potential percentage of infants with a favorable outcome.
Whether intensive care should be considered mandatory (i.e., given even if the parents object),
optional, investigational, or unwarranted (i.e., not given even if requested by the parents) can
be considered in terms of the likelihood of a benefit.5
In deciding whether to administer intensive care, Paris39 contends that “The best one can do
… is to make a human judgment based on probabilities.” Physicians should do their best to
estimate and interpret these probabilities in counseling parents.40
Whatever minimum probability of a favorable outcome is judged to warrant intensive care,
consideration of multiple factors is likely to promote treatment decisions that are less arbitrary,
more individualized, more transparent, and better justified than decisions based solely on
gestational-age thresholds. A simple Web-based tool (www.nichd.nih.gov/neonatalestimates)
allows clinicians to use our findings in estimating the likelihood that intensive care will benefit
individual infants, after considering the extent to which outcomes in their center might differ
from those we identified.
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Figure 1. Observed and Maximum Potential Rates of Survival and Survival without Profound
Impairment
Panel A shows observed and maximum potential survival, and Panel B shows survival without
profound impairment. Both rates are shown for an adjusted age of 18 to 22 months and
calculated according to gestational age, sex, and birth weight for all of the smallest and most
immature infants in the study.
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Table 1
Characteristics at Birth, Outcomes before Discharge, and Outcomes at a Corrected Age of 18 to 22 Months*
Variable
All Infants
(N = 4446)
Infants Who Received
Intensive Care
(N = 3702)
Infants Who Did Not Receive
Intensive Care
(N = 744)
Characteristics at birth
Prenatal care (%) 92 93 90†
Delivery by cesarean section (%) 42 48 9‡
Use of antenatal corticosteroids (%) 71 80 28‡
Race or ethnic group (%)†§
 Black 45 45 48
 White 35 36 31
 Hispanic 17 17 17
Singleton birth (%) 76 76 78
Female sex (%) 46 47 44
Gestational age (wk) 23.9±0.99 24.2±0.82 22.7±0.78‡
Birth weight (g) 648±124 670±118 536±84‡
Apgar score ≤3 (%)
 At 1 min 58 50 98‡
 At 5 min 28 15 98‡
Predischarge outcomes
Death (%) 49 38 100¶
Major morbidity (%)‖ 50 60 NA¶
Death or major morbidity (%)‖ 66 76 100¶
Median no. of ventilator days (5th–95th percentile) 19 (0–83) 26 (0–87) 0 (0–0)¶
Median no. of hospital days (5th–9th percentile) 72 (0–168) 88 (0–177) 0 (0–0)¶
Outcomes at 18–22 mo**
Death (%) 49 42 100¶
Death or profound impairment (%) 61 53 100¶
Death or impairment (%) 73 67 100¶
*
The study infants excluded 57 infants with a birth weight of more than 1000 g, 7 with ambiguous sex, 127 with major anomalies, 82 with a birth weight
that exceeded the 97th percentile for gestational age, and 31 survivors who did not undergo mechanical ventilation. (The percentage of infants with each
predischarge outcome was virtually identical for study infants and for all infants at 22 to 25 weeks of gestational age, including exclusions.) Plus–minus
values are means ±SD. NA denotes not applicable.
†
P<0.05 for infants given intensive care as compared with infants not given intensive care.
‡
P<0.001 for infants given intensive care as compared with infants not given intensive care.
§
Race or ethnic group was assigned by maternal report.
¶
The P value is not meaningful for this comparison.
‖
Major morbidity was defined as bronchopulmonary dysplasia requiring oxygen administration at 36 weeks' gestation, necrotizing enterocolitis requiring
surgery, retinopathy of prematurity requiring laser therapy or surgery, grade III or IV intracranial hemorrhage, or white-matter injury detected on
ultrasonographic examination.
**
Outcomes were determined for 4165 infants, including 3421 who received intensive care. Data for infants not examined at 18 to 22 months were
excluded from the denominator in analyses of death or profound impairment or death or impairment, but they were not excluded from analyses of death.
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Table 3
Comparison of Models Using Gestational Age Alone with Models Using Five Factors*
Outcome Gestational-Age Model Five-Factor Model P Value
Death
Mean absolute difference (%)† 11.9 2.8 <0.001
Range of values for observed minus estimated outcomes (%)† −21 to 35 −11 to 16 NA
Area under the ROC curve (95% CI)‡ 0.709 (0.692–0.726) 0.753 (0.737–0.769) <0.001
Death or profound impairment
Mean absolute difference (%)† 11.2 3.2 <0.001
Range of values for observed minus estimated outcomes (%)† −27 to 30 −7 to 14 NA
Area under the ROC curve (95% CI)‡ 0.704 (0.686–0.721) 0.751 (0.735–0.767) <0.001
*
The five factors are birth weight, gestational age, sex, exposure or nonexposure to antenatal corticosteroids, and singleton or multiple birth. NA denotes
not applicable, and ROC receiver operating characteristic.
†
The range of values for observed minus estimated percent differences are for 24 subgroup combinations of the five risk factors. P values were determined
by chi-square analysis.
‡
The statistical comparison between the areas under the ROC curves is based on chi-square analysis, calculated with the use of a modified ROC macro
in SAS software (SAS Institute). The ROC analysis indicates that the five-factor models were superior. Hosmer–Lemeshow goodness-of-fit tests derived
from an equivalent fixed-effects model were not significant; these findings also provide support for the five-factor models.
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Table 4
Mean Resource Use per Survivor and per Survivor without Profound Impairment at a Corrected Age of 18 to
22 Months
Resource Use Gestational Age (wk)
22 23 24 25
Per survivor
Total no. of ventilator days
 Male 119 88 63 43
 Female 90 73 58 37
Total no. of hospital days
 Male 222 181 145 121
 Female 168 163 136 111
Per survivor without profound impairment
Total no. of ventilator days
 Male 266 135 85 53
 Female 113 103 70 43
Total no. of hospital days
 Male 498 272 193 149
 Female 206 231 164 127
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